Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | BCHE | P06276 | 1/20 | 0.51 |
| ▸ | TYR | P14679 | 1/20 | 0.51 |
| ▸ | ACHE | P22303 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | HPGD | P15428 | 3/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | CA2 | P00918 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.46 |
| ▸ | EGFR | P00533 | 1/20 | 0.46 |
| ▸ | FYN | P06241 | 1/20 | 0.46 |
| ▸ | MMP2 | P08253 | 1/20 | 0.46 |
| ▸ | MMP9 | P14780 | 1/20 | 0.46 |
| ▸ | MMP8 | P22894 | 1/20 | 0.46 |
| ▸ | CA6 | P23280 | 1/20 | 0.46 |
| ▸ | CDK2 | P24941 | 1/20 | 0.46 |
| ▸ | MMP12 | P39900 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9325675 | 0.89 | GABRA1 (0.54) | TSHRBCHETYRACHELMNA | |
| SCHEMBL5587506 | 0.88 | BCHE (0.46) | TSHRBCHETYRACHELMNA | |
| SCHEMBL27283526 | 0.87 | BCHE (0.45) | TSHRBCHETYRACHELMNA | |
| SCHEMBL27689842 | 0.85 | TSHR (0.47) | TSHRBCHETYRACHELMNA | |
| SCHEMBL27468451 | 0.85 | BCHE (0.48) | TSHRBCHETYRACHELMNA | |
| SCHEMBL5590244 | 0.85 | BCHE (0.44) | TSHRBCHETYRACHELMNA | |
| SCHEMBL27848622 | 0.84 | ACHE (0.43) | TSHRBCHETYRACHELMNA | |
| SCHEMBL27436792 | 0.82 | BCHE (0.42) | TSHRBCHETYRACHELMNA | |
| SCHEMBL282881 | 0.82 | TSHR (0.68) | TSHRBCHETYRACHELMNA | |
| SCHEMBL4310619 | 0.81 | GABRA1 (0.71) | TSHRLMNAHPGDCA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7247687-B2 | Late transition metal catalysts for olefin polymerization and oligomerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2007-07-24 | — | — | US | disclosed |
| EP-1521758-B1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | EXXONMOBIL CHEM PATENTS INC (US) | 2006-05-24 | — | — | EP | disclosed |
| US-20060047094-A1 | Late transition metal catalysts for olefin polymerization and oligomerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2006-03-02 | — | — | US | disclosed |
| CN-1216029-C | Process for removing titanium oxide or iron oxide from depolymerization products obtained by glycolysis of polyesters contg. titanium oxide or iron oxide with ethylene glycol | AIES CO LTD (JP) | 2005-08-24 | — | — | CN | disclosed |
| EP-1521758-A1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | Exxonmobil Chemical Patents Inc. (US) | 2005-04-13 | — | — | EP | disclosed |
| CN-1195727-C | Method for producing bis-beta-hydroxyethyl terephthalate and method for purifying same | AIES CO LTD (JP) | 2005-04-06 | — | — | CN | disclosed |
| CN-1511821-A | Bis-beta-hydroxyethyl terephthalate production process and purification process | ��ʽ���簮������� | 2004-07-14 | — | — | CN | disclosed |
| CN-1511823-A | Bis-beta-hydroxyethyl terephthalate production process and purification process | ��ʽ���簮������� | 2004-07-14 | — | — | CN | disclosed |
| WO-2004007509-A1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2004-01-22 | — | — | WO | disclosed |
| CN-1133681-C | Method of polymerizing deionized bis-beta-hydroxyethyl terephthalate | ��ʽ���簮������� | 2004-01-07 | — | — | CN | disclosed |
| CN-1327459-A | Polymerization method of deionized bis-beta-hydroxyethyl terephthalate | AIES CO LTD (JP) | 2001-12-19 | — | — | CN | disclosed |
| CN-1321143-A | Process for removing titanium oxide or iron oxide from depolymerization products obtained by glycolysis of polyesters contg. titanium oxide or iron oxide with ethylene glycol | AIES CO LTD (JP) | 2001-11-07 | — | — | CN | disclosed |
| CN-1320113-A | Method for producing bis-beta-hydroxyethyl terephthalate and method for purifying same | AIES CO LTD (JP) | 2001-10-31 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060047094-A1 | Late transition metal catalysts for olefin polymerization and oligomerization | MLX, LOX, LMTK3 | TSHR 4680/4885BCHE 4508/4885TYR 1073/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.